These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4577254)

  • 1. Role of fluphenazine decanoate in lessening the burden of chronic schizophrenics on the community.
    Stevens BC
    Psychol Med; 1973 May; 3(2):141-58. PubMed ID: 4577254
    [No Abstract]   [Full Text] [Related]  

  • 2. The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazine.
    Falloon I; Watt DC; Shepherd M
    Psychol Med; 1978 May; 8(2):265-74. PubMed ID: 418431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients.
    Denham J; Adamson L
    Acta Psychiatr Scand; 1971; 47(4):420-30. PubMed ID: 4336483
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study of two long acting phenothiazine preparations, fluphenazine-enanthate and fluphenazine-decanoate.
    Kurland AA; Richardson JH
    Psychopharmacologia; 1966; 9(4):320-7. PubMed ID: 4871473
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of fluphenazine upon social and vocational functioning in remitted schizophrenics.
    Rifkin A; Quitkin F; Kane J; Klein DF; Ross D
    Biol Psychiatry; 1979 Jun; 14(3):499-508. PubMed ID: 224958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
    Kelly HB; Freeman HL; Banning B; Schiff AA
    Int Pharmacopsychiatry; 1977; 12(1):54-64. PubMed ID: 406212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fluphenazine decanoate, oral fluphenazine, and placebo in remitted outpatient schizophrenics.
    Rifkin A; Quitkin F; Rabiner CJ; Klein DF
    Psychopharmacol Bull; 1976 Apr; 12(2):24-6. PubMed ID: 769022
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia.
    Leong OK; Wong KE; Tay WK; Gill RC
    Singapore Med J; 1989 Oct; 30(5):436-40. PubMed ID: 2575796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient maintenance of chronic schizophrenics with long-acting fluphenazine.
    Daniel GR; Schiff AA
    Br Med J; 1973 Apr; 2(5860):244. PubMed ID: 4573207
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Pinto R; Bannerjee A; Ghosh N
    Acta Psychiatr Scand; 1979 Oct; 60(4):313-22. PubMed ID: 390972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.
    McLaren S; Cookson JC; Silverstone T
    Int Clin Psychopharmacol; 1992 Nov; 7(2):67-72. PubMed ID: 1487623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
    Knights A; Okasha MS; Salih MA; Hirsch SR
    Br J Psychiatry; 1979 Dec; 135():515-23. PubMed ID: 394794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
    Wistedt B
    Acta Psychiatr Scand; 1981 Jul; 64(1):65-84. PubMed ID: 7032224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    Wistedt B
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings].
    Rifkin A; Quitkin F; Kane J; Klein DF
    Psychopharmacol Bull; 1977 Apr; 13(2):49-50. PubMed ID: 323910
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.
    MacCrimmon DJ; Saxena B; Foley P; Grof P
    Neuropsychobiology; 1978; 4(6):360-5. PubMed ID: 692838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The social value of fluphenazine decanoate.
    Stevens B
    Acta Psychiatr Belg; 1976; 76(5):792-804. PubMed ID: 799897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels.
    Jayaram G; Coyle J; Tune L
    J Clin Psychiatry; 1986 May; 47(5):247-8. PubMed ID: 3700342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and work performance variables in phenothiazine therapy of schizophrenia.
    Chacon C; Harper P
    Acta Psychiatr Scand; 1973; 49(1):65-76. PubMed ID: 4572169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.